Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Godavari Drugs Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Godavari Drugs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Godavari Drugs - Dispatch Of Letter To Shareholders

    4 Sep 2025, 1:22PM Please find enclosed herewith copy of letter send to shareholders (whose email addresses are not registered with Company/RTA/Depositary Participants)
  • Godavari Drugs - Notice Of 37Th Annual General Meeting Of The Company

    3 Sep 2025, 3:53PM Stakeholders are hereby informed that the 37th Annual General Meeting of the Company is schedule to be held on 27th September, 2025. Notice of the sam
  • Godavari Drugs - Reg. 34 (1) Annual Report.

    3 Sep 2025, 3:44PM Please find enclosed Annual report 2024-25 of Godavari Drugs Limited
  • Godavari Drugs - Intimation Of Book Closure For The Purpose Of 37Th Annual General Meeting

    2 Sep 2025, 1:55PM This is to inform you that the Register of Members will remain closed from 21st September, 2025 to 27th September, 2025 for the purpose of 37th Annua
  • Godavari Drugs Q1 net profit down 36.20% at Rs 1.04 cr

    13 Aug 2025, 8:30PM The company reported standalone net profit of Rs 1.04 crore for the quarter ended June 30, 2025 as compared to Rs 1.63 crore in the same period last y
  • Godavari Drugs - Shareholder Meeting / Postal Ballot - 37Th Annual General Meeting Scheduled On 27Th September 2025

    13 Aug 2025, 6:07PM Pursuant to Regulation 30 of the SEBI (LODR) regulations 2015, We wish to inform you that the 37th Annual General Meeting (AGM) of the Members of Goda
  • Godavari Drugs - Un-Audited Financial Results For The Period Ended 30.06.2025

    13 Aug 2025, 5:51PM Un-Audited Financial Results For The Period Ended 30.06.2025
  • Godavari Drugs - Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2025

    13 Aug 2025, 5:42PM Pursuant to Regulations 30 and 33 of the SEBI (LODR) Regulations, 2015, we wish to inform that the Board of Directors at its meeting held on 13th Augu
  • Godavari Drugs - Rescheduling Of 37Th Annual General Meeting (AGM) Of The Company

    1 Aug 2025, 5:04PM 37th Annual General Meeting (\AGM\) of the Company, originally scheduled to be held on 28th August, 2025, has been rescheduled. The revised date, time
  • Godavari Drugs - Board Meeting Intimation for Unaudited Standalone Financial Results Of The Company For The First Quarter End

    1 Aug 2025, 4:56PM Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and a
  • Godavari Drugs has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    15 Jul 2025, 5:20PM As of June 2025, 52.63% is owned by Indian Promoters and 47.37% by Public. <p align=justify> Top five Promoters holding highest number of shares of Go
  • Godavari Drugs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Jul 2025, 4:54PM Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2025

Key fundamentals

Evaluate the intrinsic value of Godavari Drugs Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 94.5909 66.9135 49.9747 52.4646 46.3334
Liabilities 94.5909 66.9135 49.9747 52.4646 46.3334
Equity 7.5305 7.5305 7.5305 7.5305 7.5305
Gross Profit 13.3043 9.9208 11.29 9.8269 6.0353
Net Profit 5.5489 3.7858 5.2453 4.128 2.0007
Cash From Operating Activities 18.4136 13.2171 11.2298 1.3278 6.2435
NPM(%) 3.54 2.37 3.25 3.36 2.09
Revenue 156.7119 159.6248 161.1062 122.6701 95.6977
Expenses 143.4076 149.704 149.8162 112.8432 89.6624
ROE(%) 12.8 8.73 12.1 9.52 4.61

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Godavari Drugs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 801.00 -1.01 72.72 48.77 301.39 0.62
Lotus Eye Hospital and Institute Ltd 119.50 -2.85 389.61 177.70 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 22.01 0.23 0.00 368.97 -39.50 0.00
Astec Lifesciences Ltd 823.00 -1.44 0.00 167.58 -604.77 0.00

Company Info

GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju, Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class 'C' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989. MAIN OBJECTS OF THE COMPANY: The main objects at the Company as detailed in the Memorandum at Association of the Company are: 1. To manufacture, refine, purchase, sell, prepare, import, export all classes and kinds of drugs including pharmaceutical preparations and formulations, fine organics and inorganic chemicals, raw materials and intermediates for drugs. 2. To manufacture and/or deal in all types at drugs, chemicals, pharmaceuticals and intermediates on loan licence basis. 3. To undertake, promote, encourage, initiate, assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance, monetary or otherwise, as may be required for the purpose. 2012 -Godavari Drugs Ltd has informed that the Board has appointed Mr. Mohit Jaju as an Additional Director effective from May 10, 2012

GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju, Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class 'C' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989. MAIN OBJECTS OF THE COMPANY: The main objects at the Company as detailed in the Memorandum at Association of the Company are: 1. To manufacture, refine, purchase, sell, prepare, import, export all classes and kinds of drugs including pharmaceutical preparations and formulations, fine organics and inorganic chemicals, raw materials and intermediates for drugs. 2. To manufacture and/or deal in all types at drugs, chemicals, pharmaceuticals and intermediates on loan licence basis. 3. To undertake, promote, encourage, initiate, assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance, monetary or otherwise, as may be required for the purpose. 2012 -Godavari Drugs Ltd has informed that the Board has appointed Mr. Mohit Jaju as an Additional Director effective from May 10, 2012

Read More

Parent Organisation

Godavari Drugs Ltd.

Founded

02/12/1987

Managing Director

Mr.Mukund Kakani

NSE Symbol

FAQ

The current price of Godavari Drugs Ltd is

The 52-week high for Godavari Drugs Ltd is

The market capitalization of Godavari Drugs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Godavari Drugs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Godavari Drugs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Godavari Drugs Ltd shares.

The CEO of Godavari Drugs Ltd is Mr.Mukund Kakani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT